In this context, the findings that ABA-C-treated mice exhibit increased expression of browning markers such as UCP1 and PGC-1α underscore the potential of this supplementation to stimulate energy expenditure and combat obesity. Here, UCP1 is linked to obesity due to melanocortin 4 receptor deficiency.